Format

Send to

Choose Destination
Cell Stem Cell. 2017 Oct 5;21(4):415-416. doi: 10.1016/j.stem.2017.09.013.

E Pluribus Unum ("Out of Many, One"): CRISPR Modeling of Myeloid Expansion.

Author information

1
Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA.
2
Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA 94720, USA; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA. Electronic address: jcorn@berkeley.edu.

Abstract

In this issue of Cell Stem Cell, Tothova et al. (2017) demonstrate a promising way to model the complex genetics of clonal hematopoiesis and myeloid disorders using CRISPR-Cas9 genome editing in human hematopoietic stem and progenitor cells. Their approach opens the door to genotype-specific pharmacologic testing.

PMID:
28985519
DOI:
10.1016/j.stem.2017.09.013
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center